Ralph Lauren CapEx decreased by 19.4% to $75.60M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 23.5%, from $61.20M to $75.60M. Over 3 years (FY 2022 to FY 2025), CapEx shows an upward trend with a 9.0% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $28.20M | $35.20M | $50.20M | $53.30M | $39.40M | $44.50M | $72.00M | $61.60M | $39.60M | $42.80M | $42.50M | $39.90M | $33.40M | $41.70M | $61.20M | $79.90M | $187.30M | $93.80M | $75.60M |
| QoQ Change | — | +24.8% | +42.6% | +6.2% | -26.1% | +12.9% | +61.8% | -14.4% | -35.7% | +8.1% | -0.7% | -6.1% | -16.3% | +24.9% | +46.8% | +30.6% | +134.4% | -49.9% | -19.4% |
| YoY Change | — | — | — | — | +39.7% | +26.4% | +43.4% | +15.6% | +0.5% | -3.8% | -41.0% | -35.2% | -15.7% | -2.6% | +44.0% | +100.3% | +460.8% | +124.9% | +23.5% |
| Segment | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 |
|---|---|---|---|---|---|---|---|---|
| Corporate | $10.33M | $8.78M | $8.78M | $8.78M | — | $9.40M | $16.90M | $20.60M |
| Asia segment | $17.10M | $12.25M | $12.25M | $12.25M | $12.25M | $8.40M | $12.50M | $17.60M |
| Europe segment | $8.58M | $6.30M | $6.30M | $6.30M | $6.30M | $6.60M | $3.70M | $12.00M |
| North America segment | $18.38M | $13.88M | $13.88M | $13.88M | $13.88M | $9.00M | $8.60M | $11.00M |
| Other non-reportable segments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — |
| Total | $61.60M | $39.60M | $42.80M | $42.50M | $39.90M | $33.40M | $41.70M | $61.20M |
Other non-reportable segments is derived from annual filings.
Other non-reportable segments was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.